First Mercantile Trust’s NxStage Medical Inc. NXTM Stock Holding History

First Mercantile Trust’s Portfolio NXTM Stock Details NXTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-8,679	Closed	-$218K	–	846
2017 Q2	$218K	Sell	8,679 -2,755	-24%	-$68.2K	0.04%	544
2017 Q1	$307K	Buy	+11,434	New	+$316K	0.05%	478
2016 Q4	–	Sell	-8,961	Closed	-$224K	–	920
2016 Q3	$224K	Buy	+8,961	New	+$209K	0.03%	596

Other funds holding NXTM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

PCM

Pennant Capital Management Summit, New Jersey $212M AUM 19.37% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

First Mercantile Trust's NXTM Position: Q3 2017 in Review

First Mercantile Trust sold out of NxStage Medical Inc. (NXTM) in Q3 2017, closing a stake of 8,679 shares — an estimated $218K sold.

First Mercantile Trust first reported a position in NXTM in Q3 2016 and held it in 3 quarters. The position peaked at $307K in Q1 2017. 168 funds tracked by Wall St. Rank hold NXTM as of Q3 2017.

First Mercantile Trust reported no remaining NxStage Medical Inc. position as of Q3 2017 after selling out during the quarter.
First Mercantile Trust sold 8,679 NxStage Medical Inc. shares in Q3 2017, an estimated $218K.
First Mercantile Trust first reported a position in NxStage Medical Inc. in Q3 2016 and held it in 3 quarters.
First Mercantile Trust's NxStage Medical Inc. position peaked at $307K in Q1 2017.
168 funds tracked by Wall St. Rank held NxStage Medical Inc. as of Q3 2017.

Based on First Mercantile Trust's 13F filing for Q3 2017, filed 13 Nov 2017.